RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Verily
V

Verily portfolio

Verily has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $95M.
Latest deal: Culture Biosciences · Oct 14, 2021.
About this page

Its most recent investment on record is Culture Biosciences's $80M Series B+ round in October 2021, alongside Craft Ventures, Cultivian Sandbox Ventures, Synthesis Capital and 6 others. That company is in Health and bio. It has co-invested with Craft Ventures, S32 and E14 Fund, most often Craft Ventures (2 rounds).

What Verily invests in

How Verily invests

StageDealsCapital in rounds
Series B+ 1 50%$80M
Series A 1 50%$15M
YearDealsCapital in rounds
2020 1 50%$15M
2021 1 50%$80M

Verily portfolio companies

CompanyRound with VerilyTotal raisedLatest raise
CCulture Biosciences
Health and bio
 Series B+ · $80M$95MDec 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Verily. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Verily, which is a subset of its real portfolio. API: /api/v1/investors/verily (get a free API key). More: the most active VC firms and new venture capital funds.